Meta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitamin E supplementation
Food and Drug Administration (FDA) approved a generic version of Saxenda, a commonly prescribed glucagon-like peptide-1 receptor agonist (GLP-1)
Horm Metab Res 36:755760 [DOI] [PubMed] [Google Scholar] Chu ZL, Carroll C, Alfonso J, Gutierrez V, He H, Lucman A, Pedraza M, Mondala H, Gao H, Bagnol D, Chen R, Jones RM, Behan DP, Leonard J 2008 A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release
These are not marginal changes
Retrieved 24 February 2022